Nyra Health Secures €4.5M in Oversubscribed Seed Round to Boost Digital Therapy Platform
Vienna-based Nyra Health Raises €4.5M in Seed Funding to Expand Neurological Digital Therapy Platform and Scale Presence in DACH Region.
Funding Round Info:
Vienna-based startup, Nyra Health, has successfully raised €4.5 million in an oversubscribed seed funding round. The round was co-led by MassMutual Ventures (MMV) and Wellington Partners. Nyra Health, founded in 2020, is a digital therapy platform that provides personalized therapy plans for individuals with neurological conditions. The platform, which was previously known as myReha, offers over 35,000 interactive exercises to support patients recovering from neurological illnesses such as stroke, dementia, and long COVID-19 symptoms. The fresh capital will be used to scale the company's presence in the DACH region (Germany, Austria, and Switzerland), enhance its AI technology, and lay the groundwork for expansion into English-speaking markets.
About Nyra Health:
Nyra Health, headquartered in Vienna, Austria, is a pioneering healthcare technology company that was established in 2020. The company has developed an innovative tablet application that leverages artificial intelligence and evidence-based neurological research to provide a revolutionary form of therapy. The application is designed to support individuals with neurological conditions, offering a personalized and interactive approach to therapy. Through its advanced technology, Nyra Health is transforming the landscape of neurological rehabilitation, making therapy more accessible and effective for patients worldwide.
About MassMutual Ventures (MMV):
MassMutual Ventures (MMV) is a multistage, global venture capital firm that specializes in investing in enterprise software, cybersecurity, financial technology, digital health, and climate technology companies. Their mission is to accelerate the growth of the companies they partner with by providing not just capital, but also valuable connections and expert advice. MMV's portfolio includes a diverse range of companies, from BondEvalue, which focuses on the electronification of bond markets, to Qure, a healthtech company that uses deep learning technology to identify and localize abnormalities on medical scans. The firm recently welcomed Timothy Krysiek as the Managing Partner of MMV's Climate Tech Fund, demonstrating their commitment to environmental sustainability.
About Wellington Partners:
Wellington Partners is a leading European venture capital firm that has been supporting entrepreneurs since 1998. They specialize in investing in early and growth-stage life science companies in sectors such as therapeutics, medical devices, diagnostics, digital health, and industrial biotechnology. Wellington Partners is dedicated to helping entrepreneurs turn their innovative ideas into reality and become global leaders in their respective fields. They focus on companies from Germany, Europe, and beyond that offer breakthrough and truly innovative technologies. With a highly experienced team, a strong track record, and a diversified portfolio, Wellington Partners enables entrepreneurial vision and helps to unlock potential. Their portfolio includes 58 life science investments, with a total of EUR 590 million in life science funds, and they have achieved 27 life science exits, including IPOs and trade sales.